Related references
Note: Only part of the references are listed.Current Understanding of Modes of Action of Multicomponent Bioactive Phytochemicals: Potential for Nutraceuticals and Antimicrobials
Michael Wink
ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY (2022)
Turmeric-Induced Hepatotoxicity: Report of 2 Cases
Aalam Sohal et al.
INTERNATIONAL MEDICAL CASE REPORTS JOURNAL (2021)
Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease
Chiara Cerletti et al.
BRITISH JOURNAL OF NUTRITION (2020)
The effects of curcumin supplementation on body weight, body mass index and waist circumference: a systematic review and dose-response meta-analysis of randomized controlled trials
Seyed Mohammad Mousavi et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2020)
Metabolomic and Lipidomic Signatures of Metabolic Syndrome and its Physiological Components in Adults: A Systematic Review
Stephanie Monnerie et al.
SCIENTIFIC REPORTS (2020)
Medicinal plants with concomitant anti-diabetic and anti-hypertensive effects as potential sources of dual acting therapies against diabetes and hypertension: A review
Chika Ifeanyi Chukwuma et al.
JOURNAL OF ETHNOPHARMACOLOGY (2019)
Nanoformulations of natural products for management of metabolic syndrome
Yasamin Davatgaran Taghipour et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials
C. Michael White et al.
PHARMACOLOGICAL RESEARCH (2019)
Curcumin Attenuates Adipogenesis by Inducing Preadipocyte Apoptosis and Inhibiting Adipocyte Differentiation
Liang-Yi Wu et al.
NUTRIENTS (2019)
The Effect of Curcumin on Serum Copper and Zinc and Zn/Cu Ratio in Individuals with Metabolic Syndrome: A Double-Blind Clinical Trial
Hamide Safarian et al.
JOURNAL OF DIETARY SUPPLEMENTS (2019)
The Effects of Curcumin on Serum Heat Shock Protein 27 Antibody Titers in Patients with Metabolic Syndrome
Farzaneh Mohammadi et al.
JOURNAL OF DIETARY SUPPLEMENTS (2019)
Lipid-modifying activity of curcuminoids: A systematic review and meta-analysis of randomized controlled trials
Luis E. Simental-Mendia et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)
Cytochrome P450 Structure, Function and Clinical Significance: A Review
Palrasu Manikandan et al.
CURRENT DRUG TARGETS (2018)
Dietary Intake of Curcumin Improves eIF2 Signaling and Reduces Lipid Levels in the White Adipose Tissue of Obese Mice
Masuko Kobori et al.
SCIENTIFIC REPORTS (2018)
The Effects of Curcumin on Glycemic Control and Lipid Profiles Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Reza Tabrizi et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
The emerging role of curcumin for improving vascular dysfunction: A review
Marilyn S. Campbell et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2018)
Effects of Turmeric and Curcumin Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study
Christine T. Peterson et al.
JOURNAL OF EVIDENCE-BASED INTEGRATIVE MEDICINE (2018)
A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice
Hubert Plovier et al.
NATURE MEDICINE (2017)
Inflammation, metaflammation and immunometabolic disorders
Gokhan S. Hotamisligil
NATURE (2017)
Metabolic syndrome: pathophysiology, management, and modulation by natural compounds
Yogita Rochlani et al.
THERAPEUTIC ADVANCES IN CARDIOVASCULAR DISEASE (2017)
Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
Yunes Panahi et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2016)
Effects of Tetrahydrocurcumin on Tumor Growth and Cellular Signaling in Cervical Cancer Xenografts in Nude Mice
Bhornprom Yoysungnoen et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Curcumin and resveratrol in combination modulate drug-metabolizing enzymes as well as antioxidant indices during lung carcinogenesis in mice
Y. Liu et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2015)
Targeting metabolic disorders by natural products
Ozra Tabatabaei-Malazy et al.
JOURNAL OF DIABETES AND METABOLIC DISORDERS (2015)
Mitochondrial dysfunction and insulin resistance: an update
Magdalene K. Montgomery et al.
ENDOCRINE CONNECTIONS (2015)
Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity
Ana Paula Arruda et al.
NATURE MEDICINE (2014)
Comparative absorption of curcumin formulations
Ralf Jaeger et al.
NUTRITION JOURNAL (2014)
Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies
Yow-Wen Hsieh et al.
SCIENTIFIC REPORTS (2014)
You are what you eat, or are you? The challenges of translating high-fat-fed rodents to human obesity and diabetes
M. Lai et al.
NUTRITION & DIABETES (2014)
The role of leptin/adiponectin ratio in metabolic syndrome and diabetes
Patricio Lopez-Jaramillo et al.
HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION (2014)
Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implications
E. Ch Yiannakopoulou
PHARMACOGENOMICS JOURNAL (2013)
Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study
Elena Maria Yubero-Serrano et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
Foundation review: Progressing preclinical drug candidates: strategies on preclinical safety studies and the quest for adequate exposure
John Higgins et al.
DRUG DISCOVERY TODAY (2012)
The Targets of Curcumin
Hongyu Zhou et al.
CURRENT DRUG TARGETS (2011)
Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment
Purusotam Basnet et al.
MOLECULES (2011)
Ethnobotanical study of medicinal plants used in the management of diabetes mellitus and hypertension in the Central Region of Togo
Simplice Damintoti Karou et al.
PHARMACEUTICAL BIOLOGY (2011)
Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model
Jurgen Scholze et al.
BMC PUBLIC HEALTH (2010)
Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression
Dan Feng et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease
Daryoush Hamidi Alamdari et al.
CLINICAL BIOCHEMISTRY (2008)
Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome
Ferah Armutcu et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Curcumin is a potent inhibitor of phenol sulfotransferase (SULT1A1) in human liver and extrahepatic tissues
M Vietri et al.
XENOBIOTICA (2003)
Share Paper
